Skip to main content

Dashboard Topics Interactive Map Market Exposure Explore AI Mode How It Works

Product

Dashboard
Timeline
Finance
Map
Sources
AI Mode

Explore

Search
Topics
Tags
Entities
How It Works
Developers

Account

Sign In
Create Account
Watchlist
Notifications

Company

About
Editorial Team
Methodology
Editorial Policy
Press
Corrections
Changelog

Stay informed

Get a daily briefing of the most important geopolitical events, narrative shifts, and market signals.

Subscribe to newsletter

Legal·Privacy·Terms·Cookies·Accessibility·Contact

NarrativeRadar is a decision-support intelligence tool. It is not a news outlet, fact-checker, or investment advisor.

Developed by

Redirecting... | NarrativeRadar

Dashboard
/Exagen Inc. misses Q4 2025 earnings expectations

Exagen Inc. misses Q4 2025 earnings expectations

Exagen Inc. misses Q4 2025 earnings expectations

ArchivedVerified|3 articles|2 sources|1 blocks

Detected: Updated: Analyzed:

Finance Healthcare Earnings

Reported Facts

Observable data points shared across all narratives

•Exagen Inc. released its Q4 2025 earnings report on March 10, 2026.
•The company's reported earnings per share were below the consensus analyst forecast.
•Management discussed the factors contributing to the earnings miss during the earnings call.
•The earnings call included projections for the company's financial performance in 2026.

What Could Happen If...

▸If Exagen Inc. improves its financial performance in Q1 2026 investor confidence could increase, potentially stabilizing or raising the company's stock price.

Sign in to see all scenarios and signals.

Key Actors

Instruments

📈Exagen Inc. stock

Organizations

🏛Exagen Inc.

Source Coverage

FINANCE

3 articles

More coverage on this story

More on Exagen Inc. stock
More on Exagen Inc.

Signals

Single-block coverage

Related Events

▸PYC Therapeutics reports strong Q1 2026 financial resultsArchived ▸Earnings call transcript: Tower Semiconductor Q4 2025 beats EPS forecast, stock risesArchived ▸Tecogen Inc. reports wider Q4 2025 loss, shares fallArchived ▸Bed Bath & Beyond Prepares to Report Q4 2025 EarningsArchived ▸TAT Technologies Prepares FY 2025 Earnings ReportArchived

Primary Sources (3)

FINANCESeeking Alpha - Market NewsGambling.com Q4 2025 Earnings Preview FINANCEInvesting.com - NewsEarnings call transcript: Tegma Q4 2025 shows revenue dip, stock slips FINANCEInvesting.com - NewsEarnings call transcript: Exagen Inc. misses Q4 2025 earnings expectations

NarrativeRadar Analysis·Reviewed by M. Reyes·AI-assisted, editorially supervised·Based on 3 articles from 2 sources

Exagen Inc. reported earnings below analyst expectations for the fourth quarter of 2025. This shortfall may influence investor confidence and affect the company's stock price. The earnings call included management's commentary on financial results and the outlook for upcoming quarters.